South Africa’s Afrigen eyes Ebola vaccine role after landmark GMP certification
Culture Index
Score Breakdown
Relevance
3/25
Freshness
25/25
Authority
18/20
Brand Signal
6/15
Depth
3/15
5-Axis Cultural Radar
As the Ebola outbreak in Democratic Republic of the Congo crosses into Uganda, South Africa’s Afrigen biotech laboratory is participating in proposals to develop an effective vaccine.
